Education
About Us
Working with TipRanks
Follow Us
Baxter International (BAX)
NYSE:BAX
BAX Stock Chart & Stats
$17.69
$0.05(0.17%)
At close: 4:00 PM EST
$17.69
$0.05(0.17%)
Day’s Range― - ―
52-Week Range$17.40 - $37.74
Previous CloseN/A
Volume899.70K
Average Volume (3M)7.84M
Market Cap
$9.13B
Enterprise Value$19.66B
Total Cash (Recent Filing)$1.73B
Total Debt (Recent Filing)$9.71B
Price to Earnings (P/E)―
Beta0.81
Next Earnings
Feb 12, 2026EPS Estimate
0.55Last Dividend Ex-Date
Aug 29, 2025Dividend Yield3.68%
Share Statistics
EPS (TTM)0.69
Shares Outstanding514,055,800
10 Day Avg. Volume9,822,079
30 Day Avg. Volume7,844,342
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)2.14
Price to Sales (P/S)1.40
P/FCF Ratio26.60
Enterprise Value/Market Cap2.15
Enterprise Value/Revenue1.78
Enterprise Value/Gross Profit5.04
Enterprise Value/Ebitda19.15
Forecast
1Y Price Target
$23.67Price Target Upside33.80% Upside
Rating ConsensusHold
Number of Analyst Covering10
EPS Forecast (FY)2.37
Revenue Forecast (FY)$11.31B
Bulls Say, Bears Say
Bulls Say
EarningsDespite challenges, adjusted EPS of $0.69 surpassed the consensus estimate of $0.60, aided by a lower-than-expected tax rate.
Financial HealthThe dividend cut is seen as a first sign of how aggressive new CEO Andrew Hider will be in improving BAX’s overall financial health via deleveraging and an improving balance sheet.
Operational EfficiencyCEO Andrew Hider introduced a near-term action plan focusing on business stabilization, balance sheet enhancement, and operational efficiency improvement.
Bears Say
Growth ChallengesThe 2026 outlook moves meaningfully lower, demonstrating anticipation of BAX facing continued headwinds.
Guidance And OutlookBAX lowered FY25 sales growth and EPS guidance, raising concerns about future performance.
Sales PerformanceBAX shares came under pressure delivering a 3Q25 sales miss across all businesses except Advanced Surgery and also cutting its quarterly dividend.
Baxter International News
BAX FAQ
What was Baxter International’s price range in the past 12 months?
Baxter International lowest stock price was $17.40 and its highest was $37.74 in the past 12 months.
What is Baxter International’s market cap?
Baxter International’s market cap is $9.13B.
When is Baxter International’s upcoming earnings report date?
Baxter International’s upcoming earnings report date is Feb 12, 2026 which is in 83 days.
How were Baxter International’s earnings last quarter?
Baxter International released its earnings results on Oct 30, 2025. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.598 by $0.092.
Is Baxter International overvalued?
According to Wall Street analysts Baxter International’s price is currently Undervalued.
Does Baxter International pay dividends?
Baxter International pays a Quarterly dividend of $0.17 which represents an annual dividend yield of 3.68%. See more information on Baxter International dividends here
What is Baxter International’s EPS estimate?
Baxter International’s EPS estimate is 0.55.
How many shares outstanding does Baxter International have?
Baxter International has 514,055,800 shares outstanding.
What happened to Baxter International’s price movement after its last earnings report?
Baxter International reported an EPS of $0.69 in its last earnings report, beating expectations of $0.598. Following the earnings report the stock price went down -14.541%.
Which hedge fund is a major shareholder of Baxter International?
Currently, no hedge funds are holding shares in BAX
Baxter International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$23.67 (33.80% Upside)
$23.67 (33.80% Upside)
Blogger Sentiment
Bearish
BAX Sentiment 67%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 30.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 0.1%
Last 30 Days ▲ 0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.36%
12-Months-Change
Fundamentals
Return on Equity
-4.70%
Trailing 12-Months
Asset Growth
-21.03%
Trailing 12-Months
Company Description
Baxter International
Baxter International Inc. is a global healthcare company that specializes in the development, manufacturing, and marketing of a broad range of medical products. The company operates primarily in two segments: Hospital Products and Renal. Baxter's core products include intravenous (IV) solutions, infusion systems, and renal care products like dialysis equipment. The company is dedicated to improving patient outcomes and enhancing the safety and efficiency of healthcare delivery through innovative products and therapies.
BAX Company Deck
BAX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Baxter International's earnings call highlighted revenue growth in key segments, particularly in Advanced Surgery and Healthcare Systems & Technologies. However, significant challenges exist, notably with the Infusion Therapies and Pharmaceuticals segments, as well as the decision to reduce the dividend for deleveraging purposes. The company's focus on stabilizing business operations, improving the balance sheet, and driving continuous improvement reflects a proactive approach to addressing these challenges.View all BAX earnings summariesBAX Net sales Breakdown
48.96% Medical Products and Therapies
27.75% Healthcare Systems and Technologies
22.67% Pharmaceuticals
0.63% Other
BAX Stock 12 Month Forecast
Average Price Target
$23.67
▲(33.80% Upside)
Technical Analysis
Ownership Overview
0.46% Insiders
33.79% Mutual Funds
32.85% Other Institutional Investors
7.18% Public Companies and
Individual Investors